Laddar...
Atopic dermatitis: Tofacitinib, an option for refractory disease
Atopic dermatitis (AD) is a common skin disease, associated with high burden impact in quality of live, in moderate‐severe disease severity. Several targeted drugs are under development for AD. Here, we present a patient with refractory disease to systemic traditional immunosuppressive drugs, treate...
Sparad:
| I publikationen: | Clin Case Rep |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7752607/ https://ncbi.nlm.nih.gov/pubmed/33363913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3325 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|